Douglas Thomson
Company: Proxygen GmbH
Job title: Director, Head of Medicinal Chemistry
Seminars:
Leveraging E3 Ligase-Agnostic Discovery to Identify, Optimize and Characterize Novel Cyclin K Molecular Glue Degraders 9:00 am
day: Day Two